← Back to Clinical Trials
Recruiting NCT06719258

NCT06719258 Evaluation of Gas Humidification Practices in Patients Under Invasive Mechanical Ventilation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06719258
Status Recruiting
Phase
Sponsor Laval University
Condition Humidifier Lung
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-09-20
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
MR850FP950

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2024-09-20 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

When mechanical ventilation is initiated, a humidification method should be chosen. There is two methods: heat and humidity exchanger filters or heated humidity. The second method is recognized to be more efficient, but many external factors can influence its performance. Insufficient humidity results in observable problems, such as difficult management of respiratory secretions. The study compare two heated humidifiers already used in ICU. Data will be collected retrospectively from June 1, 2021.

Eligibility Criteria

Inclusion Criteria: * ≥ 18 years old * Admitted to intensive care * Under invasive mechanical ventilation with the usual indications for the use of a heated humidifier (prolonged invasive mechanical ventilation and / or protective ventilation requiring high respiratory rates. Exclusion Criteria: * Mechanical venitilation immediately after surgery (\<24h) * Imminent extubation or planned intubation of very short duration (\<24h) * Enrolled in the SAVE-ICU study in the group receiving volatile agents with the AnaConDa system.

Contact & Investigator

Central Contact

François Lellouche

✉ francois.lellouche@criucpq.ulaval.ca

📞 418-656-8711

Frequently Asked Questions

Who can join the NCT06719258 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Humidifier Lung. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06719258 currently recruiting?

Yes, NCT06719258 is actively recruiting participants. Contact the research team at francois.lellouche@criucpq.ulaval.ca for enrollment information.

Where is the NCT06719258 trial being conducted?

This trial is being conducted at Québec, Canada.

Who is sponsoring the NCT06719258 clinical trial?

NCT06719258 is sponsored by Laval University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology